Statement of Changes in Beneficial Ownership (4)
March 03 2020 - 4:13PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Crum Brian T |
2. Issuer Name and Ticker or Trading Symbol
LEXICON PHARMACEUTICALS, INC.
[
LXRX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) VP, General Counsel & Secr. |
(Last)
(First)
(Middle)
8800 TECHNOLOGY FOREST PL |
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/28/2020 |
(Street)
THE WOODLANDS, TX 77381
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 2/28/2020 | | M | | 2515 | A | (1) | 25440 | D | |
Common Stock | 2/28/2020 | | M | | 1518 | A | (1) | 26958 | D | |
Common Stock | 2/28/2020 | | M | | 5119 | A | (1) | 32077 | D | |
Common Stock | 2/28/2020 | | M | | 11100 | A | (1) | 43177 | D | |
Common Stock | 2/28/2020 | | F(2) | | 6940 | D | $2.77 | 36237 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Restricted Stock Units | (1) | 2/28/2020 | | M | | | 2515 | (3) | (3) | Common Stock | 2515 | (1) | 0 | D | |
Restricted Stock Units | (1) | 2/28/2020 | | M | | | 1518 | (4) | (4) | Common Stock | 1518 | (1) | 1517 | D | |
Restricted Stock Units | (1) | 2/28/2020 | | M | | | 5119 | (5) | (5) | Common Stock | 5119 | (1) | 5118 | D | |
Restricted Stock Units | (1) | 2/28/2020 | | M | | | 11100 | (6) | (6) | Common Stock | 11100 | (1) | 22200 | D | |
Explanation of Responses: |
(1) | Each restricted stock unit represents a contingent right to receive one share of common stock. |
(2) | Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. |
(3) | Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. |
(4) | Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. |
(5) | Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. |
(6) | Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Crum Brian T 8800 TECHNOLOGY FOREST PL THE WOODLANDS, TX 77381 |
|
| VP, General Counsel & Secr. |
|
Signatures
|
/s/ Brian T. Crum | | 3/3/2020 |
**Signature of Reporting Person | Date |
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jul 2023 to Jul 2024